Yasuyuki Hirashima Selected Research

Yasuyuki Hirashima Research Topics

Disease

25	Neoplasms (Cancer) 05/2024 - 04/2003
18	Uterine Cervical Neoplasms (Cancer of the Cervix) 11/2023 - 03/2003
8	Ovarian Neoplasms (Ovarian Cancer) 07/2021 - 05/2003
6	Neoplasm Metastasis (Metastasis) 04/2017 - 04/2003
5	Carcinoma (Carcinomatosis) 11/2023 - 04/2003
4	Endometrial Neoplasms (Endometrial Cancer) 01/2023 - 10/2008
3	Nausea 02/2016 - 11/2014
3	Vomiting 02/2016 - 11/2014
2	Carcinosarcoma 01/2023 - 06/2021
2	Disease Progression 01/2023 - 01/2022
2	Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer) 01/2022 - 01/2021
2	Lymphatic Metastasis 05/2018 - 04/2014
1	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 05/2024
1	Confusion (Bewilderment) 08/2023
1	Endometrial Hyperplasia 01/2023
1	Uterine Cervical Dysplasia 10/2022
1	Papillomavirus Infections 04/2022
1	Microsatellite Instability 01/2022
1	Colorectal Neoplasms (Colorectal Cancer) 01/2022
1	Fistula 01/2022
1	Enteritis 03/2020
1	Anemia 03/2020
1	Hypesthesia (Numbness) 03/2020
1	Neuroendocrine Carcinoma 02/2017
1	Insulinoma 02/2017
1	Infections 06/2015
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 04/2014
1	Brain Neoplasms (Brain Tumor) 02/2013

Drug/Important Bio-Agent (IBA)

11	Cisplatin (Platino)FDA LinkGeneric 05/2024 - 09/2012
6	Paclitaxel (Taxol)FDA LinkGeneric 01/2022 - 07/2006
5	Proteins (Proteins, Gene)FDA Link 08/2022 - 05/2003
4	Carboplatin (JM8)FDA LinkGeneric 01/2022 - 07/2006
4	Protease Inhibitors (Protease Inhibitor)IBA 04/2004 - 04/2003
3	Papillomavirus Vaccines (HPV Vaccines)IBA 11/2023 - 04/2022
3	Messenger RNA (mRNA)IBA 04/2004 - 04/2003
3	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 07/2003 - 04/2003
2	Immune Checkpoint InhibitorsIBA 01/2024 - 01/2022
2	Immunoconjugates (Immunoconjugate)IBA 01/2023 - 08/2022
2	AntigensIBA 07/2021 - 07/2006
2	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 10/2019
2	PlatinumIBA 10/2019 - 07/2015
2	nedaplatinIBA 05/2018 - 09/2012
2	Transcription Factors (Transcription Factor)IBA 02/2017 - 04/2003
2	Aprepitant (Emend)FDA Link 02/2016 - 11/2014
2	Palonosetron (Aloxi)FDA Link 02/2016 - 11/2014
2	Olanzapine (Zyprexa)FDA Link 02/2016 - 01/2015
2	Dexamethasone (Maxidex)FDA LinkGeneric 02/2016 - 11/2014
2	Complementary DNA (cDNA)IBA 04/2004 - 04/2003
2	Pregnancy-Associated Plasma Protein-A (PAPP-A)IBA 04/2004 - 04/2003
2	Fibrinolysin FDA Link 05/2003 - 04/2003
1	Bleomycin (Blenoxane)FDA LinkGeneric 05/2024
1	Etoposide (VP 16)FDA LinkGeneric 05/2024
1	Indicators and Reagents (Reagents)IBA 05/2024
1	Amino Acids FDA Link 08/2023
1	Peptides (Polypeptides)IBA 08/2023
1	EpitopesIBA 08/2023
1	trastuzumab deruxtecanIBA 01/2023
1	human ERBB2 proteinIBA 01/2023
1	Progestins (Progestagens)IBA 01/2023
1	Topoisomerase I InhibitorsIBA 01/2023
1	ErbB Receptors (EGF Receptor)IBA 01/2023
1	Thromboplastin (Tissue Factor)IBA 08/2022
1	monomethyl auristatin EIBA 08/2022
1	tisotumab vedotinIBA 08/2022
1	Calcibiotic Root Canal SealerIBA 01/2022
1	Bevacizumab (Avastin)FDA Link 01/2022
1	Aurora Kinase AIBA 12/2021
1	tissue-factor-pathway inhibitor 2 (PP5)IBA 07/2021
1	Biomarkers (Surrogate Marker)IBA 07/2021
1	Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric 03/2020
1	taxaneIBA 10/2019
1	Gemcitabine FDA Link 10/2019
1	liposomal doxorubicin (Doxil)FDA Link 10/2019
1	S-1 plus cisplatinIBA 01/2018
1	veliparibIBA 11/2017
1	Fluorouracil (Carac)FDA LinkGeneric 10/2015
1	AntiemeticsIBA 01/2015
1	Drug CombinationsIBA 11/2014
1	Insulin-Like Growth Factor I (IGF-1)IBA 04/2004
1	Insulin-Like Growth Factor Binding Protein 4IBA 04/2004
1	Urokinase Plasminogen Activator ReceptorsIBA 04/2004

Therapy/Procedure

13	Therapeutics 01/2024 - 10/2008
11	Drug Therapy (Chemotherapy) 03/2020 - 03/2003
8	Chemoradiotherapy 08/2016 - 08/2011
7	Radiotherapy 11/2023 - 07/2006
5	Hysterectomy 01/2023 - 04/2014
4	Brachytherapy 04/2014 - 03/2003
3	Lymph Node Excision (Lymph Node Dissection) 04/2017 - 06/2015
2	Precision Medicine 01/2022 - 01/2021
2	Adjuvant Chemotherapy 05/2018 - 08/2016
1	Estrogen Replacement Therapy 05/2024
1	Minimally Invasive Surgical Procedures 11/2023
1	Immunotherapy 08/2023
1	Aftercare (After-Treatment) 03/2021
1	Semiconductors 01/2021
1	Ligation 01/2021
1	Injections 03/2020
1	Genomic Medicine 02/2020
1	Oral Administration 10/2008
1	Neoadjuvant Therapy 07/2006